Sign In
Buy EVH
$3.78
-0.180 (-4.55%)
At Close: Jun 03, 2026
Evolent's Soft Q2 Results: Why I'm Holding Anyway
08:35am, Thursday, 21'st Aug 2025
Evolent's revenue dip in Q1 was structural, not demand-driven, and Q2 shows stabilization; I expect growth to resume in the second half of 2025. New specialty contracts, incremental member growth, and
WASHINGTON , Aug. 19, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions ("Evolent"), today announced the p
WASHINGTON , Aug. 18, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions ("Evolent"), today announced that
Evolent Health, Inc. (EVH) Q2 2025 Earnings Call Transcript
06:15pm, Friday, 08'th Aug 2025
Evolent Health, Inc. (NYSE:EVH ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants John Paul Johnson - Chief Financial Officer Seth Barrie Blackley - Co-Founder, CEO & Di
Evolent Health (EVH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
09:01pm, Thursday, 07'th Aug 2025
The headline numbers for Evolent Health (EVH) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street est
Evolent Health (EVH) Reports Q2 Loss, Misses Revenue Estimates
07:16pm, Thursday, 07'th Aug 2025
Evolent Health (EVH) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of $0.09. This compares to earnings of $0.3 per share a year ago.
Evolent Announces Second Quarter 2025 Results
04:10pm, Thursday, 07'th Aug 2025
WASHINGTON , Aug. 7, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through
Earnings Preview: Evolent Health (EVH) Q2 Earnings Expected to Decline
11:08am, Thursday, 31'st Jul 2025
Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025
08:00am, Monday, 14'th Jul 2025
Company to Participate in Upcoming Conferences WASHINGTON , July 14, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with comple
Evolent announces key appointments to leadership team
08:00am, Wednesday, 09'th Jul 2025
Dr. David Lim joins Evolent as chief clinical officer John Way joins Evolent as CFO, Performance Suite WASHINGTON , July 9, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on
Evolent Health (EVH) Stock Jumps 6.9%: Will It Continue to Soar?
09:36am, Monday, 23'rd Jun 2025
Evolent Health (EVH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increa
Evolent reiterates Q2 and full year guidance for Adjusted EBITDA
06:30am, Friday, 20'th Jun 2025
Notes accelerating 2026 revenue bookings forecast Secures incremental non-dilutive financing WASHINGTON , June 20, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving
Evolent Health, Inc. (EVH) Q1 2025 Earnings Call Transcript
06:03pm, Friday, 09'th May 2025
Evolent Health, Inc. (NYSE:EVH ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Seth Blackley - Chief Executive Officer John Johnson - Chief Financial Officer Conference
Evolent Health (EVH) Reports Q1 Earnings: What Key Metrics Have to Say
03:01pm, Friday, 09'th May 2025
Although the revenue and EPS for Evolent Health (EVH) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall S
